Skip to main navigation
Skip to search
Skip to main content
The Ohio State University Home
Search content at The Ohio State University
Home
Profiles
Research units
Research output
Projects
Graft-versus-host disease: Why have we not made more progress?
Samantha M. Jaglowski
, Steven M. Devine
Center for Clinical and Translational Science
Comprehensive Cancer Center
Comprehensive Cancer Center - Innate Immunity
Internal Medicine
Internal Medicine - Hematology
Center for Regenerative Medicine and Cell-Based Therapies
Comprehensive Cancer Center - Experimental Therapeutics
Research output
:
Contribution to journal
›
Review article
›
peer-review
45
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Graft-versus-host disease: Why have we not made more progress?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Graft Versus Host Reaction
100%
Chronic Graft Versus Host Disease
100%
Allogeneic Hematopoietic Stem Cell Transplantation
50%
Biological Marker
25%
Prospective Study
25%
Hematologic Malignancy
25%
Clinical Study
25%
Acute Graft Versus Host Disease
25%
Diseases
25%
Pharmacology, Toxicology and Pharmaceutical Science
Graft Versus Host Reaction
100%
Chronic Graft Versus Host Disease
100%
Biological Marker
25%
Clinical Study
25%
Hematologic Malignancy
25%
Prospective Study
25%
Acute Graft Versus Host Disease
25%
Diseases
25%
Keyphrases
Graft-versus-host Disease (GvHD)
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
25%
New Agents
12%
Prognostic Information
12%
Corticosteroids
12%
Hematological Malignancies
12%
Inconsistency
12%
Disease Response
12%
Prospective Clinical Study
12%
Steroid-refractory
12%
Refractory Disease
12%
Fatal Complication
12%
Inclusion Criteria
12%
Second-line Treatment
12%
Host Country
12%
Frontline Treatment
12%
National Institutes of Health Consensus Criteria
12%
Immunology and Microbiology
Graft-Versus-Host Disease
100%
Chronic Graft Versus Host Disease
100%
Allogeneic Hematopoietic Stem Cell Transplantation
50%
Acute Graft Versus Host Disease
25%